NCT06560645 2026-02-02A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationPrelude TherapeuticsPhase 1 Terminated42 enrolled